{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T02:44:03Z","timestamp":1781491443200,"version":"3.54.1"},"reference-count":82,"publisher":"National Institute for Health and Care Research","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["15\/101\/16"],"award-info":[{"award-number":["15\/101\/16"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"\n Background<\/jats:title>\n Gabapentin is an anticonvulsant medication with a United Kingdom licence to treat partial seizures and neuropathic pain. It is used off-licence for acute pain and is frequently added to multimodal analgesic regimens after surgery to try and reduce opioid use while controlling pain effectively.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To test the hypothesis that gabapentin reduces opioid use after major surgery and speeds up recovery, thereby reducing postoperative hospital length of stay compared to standard multimodal analgesia.<\/jats:p>\n <\/jats:sec>\n \n Design, setting and participants<\/jats:title>\n \n The GAP study was a multicentre, blinded, randomised controlled trial in patients aged \u2265\u200518 years, undergoing cardiac, thoracic or abdominal surgery with an expected postoperative stay of \u2265\u20052 days in seven National Health Service hospitals. The trial was designed to provide 90% power to detect a difference of 12.5% in the proportion of participants discharged by the median length of stay in\n \n each<\/jats:underline>\n <\/jats:italic>\n specialty (500 participants\/specialty), which was reduced to 80% (340 participants\/specialty) due to COVID-19-related recruitment challenges.\n <\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Participants were randomised 1\u2005:\u20051 (stratified by surgical specialty) to receive either gabapentin (600\u00a0mg before surgery, 300\u00a0mg twice daily for 2 days after surgery) or placebo as an adjunct to multimodal pain regimens.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n Primary outcome was length of stay. Secondary outcomes included acute and chronic (Brief Pain Inventory) pain, total opioid use, adverse health events, health-related quality of life (-EQ-5D-5L, Short Form questionnaire-12 items physical component score and mental component score), resource use; cost-effectiveness (outcome measure quality-adjusted life-years using EQ-5D, five-level version).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n One thousand one hundred and ninety-six (cardiac 500, thoracic 346, abdominal 350) participants consented and were randomised. Baseline characteristics were well balanced across the two groups: median age: 68 years; male sex 796\/1195 (66.4%). Of the participants, 223\/1195 (18.7%) did not receive all prescribed medication or received medication out of window. There was no difference in length of stay; median placebo (\n n<\/jats:italic>\n \u2005=\u2005589): 6.15, gabapentin (\n n<\/jats:italic>\n \u2005=\u2005595): 5.94 days [hazard ratio for discharge 1.07, 95% confidence interval (0.95 to 1.20),\n p<\/jats:italic>\n \u2005=\u20050.26]. Opioid use\n in-hospital<\/jats:italic>\n differed between surgical specialties (\n p<\/jats:italic>\n \u2005=\u20050.001); in the abdominal specialty, it was significantly lower in the gabapentin group in 4 of the first 5 postoperative days [range \u221226% (\u221246% to 0%) to \u221236% (\u221252% to \u221214%)], with no differences in the cardiac specialty nor in the thoracic specialty beyond day 2.\n During follow-up<\/jats:italic>\n , opioid use was similar in the two groups across all specialties. Acute pain beyond 24 hours was similar (\n p<\/jats:italic>\n \u2005\u2265\u20050.15). The incidence of one or more serious adverse events was placebo: 189\/595 (31.7%); gabapentin: 195\/599 (32.6%). Health-related quality of life was similar [EQ-5D: mean difference \u22120.014 (\u22120.036 to 0.009), Short Form questionnaire-12 items physical component score: \u22120.87 (\u22121.71 to \u22120.04), Short Form questionnaire-12 items mental component score: at 4 weeks 0.74 (\u22121.71 to 0.42) and 4 months \u22120.55 (\u22121.61 to 0.51)]. Differences in costs and quality-adjusted life-years favoured placebo, and gabapentin was not considered cost-effective.\n <\/jats:p>\n <\/jats:sec>\n \n Limitations<\/jats:title>\n \n \n \n GAP study tests the application of gabapentin to major body cavity surgery, but not major\n non-body cavity<\/jats:italic>\n surgery, or\n non-major<\/jats:italic>\n surgery.\n <\/jats:p>\n <\/jats:list-item>\n \n The fixed dose and limited duration of gabapentin may reduce applicability to certain populations.<\/jats:p>\n <\/jats:list-item>\n \n Reducing the power to 80% reduced the ability of the trial to detect a beneficial effect of gabapentin.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Among patients undergoing major cardiac, thoracic and abdominal surgery, adding gabapentin to multimodal analgesic regimes did not result in a change in length of stay, opiate use in two specialties, acute pain, or health-related quality of life, nor was it cost-effective.<\/jats:p>\n <\/jats:sec>\n \n Future work<\/jats:title>\n \n Trials to assess the place of gabapentin in major\n non-body cavity<\/jats:italic>\n surgery (e.g. joint replacement), or\n non-major<\/jats:italic>\n (e.g. day-care) surgery should be considered.\n <\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n This trial is registered as Current Controlled Trials ISRCTN63614165.<\/jats:p>\n <\/jats:sec>\n \n Funding<\/jats:title>\n \n This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 15\/101\/16) and is published in full in\n Health Technology Assessment<\/jats:italic>\n ; Vol. 30, No. 9. See the NIHR Funding and Awards website for further award information.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3310\/plmh9787","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T10:59:57Z","timestamp":1735901997000},"page":"1-144","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Gabapentin as an adjunct to multimodal pain regimens in surgical patients: the GAP placebo-controlled RCT and economic evaluation"],"prefix":"10.3310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2039-8768","authenticated-orcid":true,"given":"Sarah","family":"Baos","sequence":"first","affiliation":[{"name":"Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6637-3705","authenticated-orcid":true,"given":"Terrie","family":"Walker-Smith","sequence":"additional","affiliation":[{"name":"Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4404-2084","authenticated-orcid":true,"given":"Mandy","family":"Lui","sequence":"additional","affiliation":[{"name":"Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4179-1369","authenticated-orcid":true,"given":"Elizabeth","family":"A Stokes","sequence":"additional","affiliation":[{"name":"Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6839-5147","authenticated-orcid":true,"given":"Jingjing","family":"Jiang","sequence":"additional","affiliation":[{"name":"Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1775-1949","authenticated-orcid":true,"given":"Maria","family":"Pufulete","sequence":"additional","affiliation":[{"name":"Bristol Heart Institute, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3635-6212","authenticated-orcid":true,"given":"Ben","family":"Gibbison","sequence":"additional","affiliation":[{"name":"Bristol Heart Institute, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9624-2615","authenticated-orcid":true,"given":"Chris","family":"A Rogers","sequence":"additional","affiliation":[{"name":"Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2026,2]]},"reference":[{"key":"key2026020917224200_ref1-bib1","doi-asserted-by":"crossref","first-page":"e041176","DOI":"10.1136\/bmjopen-2020-041176","article-title":"Effectiveness, cost-effectiveness and safety of gabapentin versus placebo as an adjunct to multimodal pain regimens in surgical patients: protocol of a placebo controlled randomised controlled trial with blinding (GAP study)","volume":"10","author":"Baos","year":"2020","journal-title":"BMJ Open"},{"key":"key2026020917224200_ref2-bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/bja\/aex137","article-title":"Frequency of surgical treatment and related hospital procedures in the UK: a national ecological study using hospital episode statistics","volume":"119","author":"Abbott","year":"2017","journal-title":"Br J Anaesth"},{"key":"key2026020917224200_ref3-bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1185\/03007995.2013.860019","article-title":"Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey","volume":"30","author":"Gan","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"key2026020917224200_ref4-bib4","doi-asserted-by":"crossref","first-page":"359.e1","DOI":"10.1016\/j.jpain.2016.11.004","article-title":"The transition of acute postoperative pain to chronic pain: an integrative overview of research on mechanisms","volume":"18","author":"Chapman","year":"2017","journal-title":"J Pain"},{"key":"key2026020917224200_ref5-bib5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s12630-012-9712-x","article-title":"Chronic pain, healthcare utilization, and quality of life following gastrointestinal surgery","volume":"59","author":"VanDenKerkhof","year":"2012","journal-title":"Can J Anaesth"},{"key":"key2026020917224200_ref6-bib6","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.athoracsur.2012.01.031","article-title":"Chronic postthoracotomy pain and health-related quality of life","volume":"93","author":"Kinney","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"key2026020917224200_ref7-bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bja.2022.03.021","article-title":"Delivery of drinking, eating and mobilising (DrEaMing) and its association with length of hospital stay after major noncardiac surgery: observational cohort study","volume":"129","author":"Oliver","year":"2022","journal-title":"Br J Anaesth"},{"key":"key2026020917224200_ref9-bib9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamasurg.2018.1039","article-title":"Association of opioid-related adverse drug events with clinical and cost outcomes among surgical patients in a large integrated health care delivery system","volume":"153","author":"Shafi","year":"2018","journal-title":"JAMA Surg"},{"key":"key2026020917224200_ref10-bib10","doi-asserted-by":"crossref","first-page":"g1251","DOI":"10.1136\/bmj.g1251","article-title":"Rates and risk factors for prolonged opioid use after major surgery: population based cohort study","volume":"348","author":"Clarke","year":"2014","journal-title":"BMJ"},{"key":"key2026020917224200_ref12-bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tips.2006.12.006","article-title":"Calcium ligands: novel modulators of neurotransmission","volume":"28","author":"Dooley","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"key2026020917224200_ref13-bib13","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/sj.bjp.0701320","article-title":"Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents","volume":"121","author":"Field","year":"1997","journal-title":"Br J Pharmacol"},{"key":"key2026020917224200_ref14-bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0920-1211(97)00084-3","article-title":"A summary of mechanistic hypotheses of gabapentin pharmacology","volume":"29","author":"Taylor","year":"1998","journal-title":"Epilepsy Res"},{"key":"key2026020917224200_ref15-bib15","author":"Chauhan","year":"2017","journal-title":"Gabapentinoids for Acute Operative Pain_Final Survey"},{"key":"key2026020917224200_ref16-bib16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/AOG.0000000000000289","article-title":"Preemptive use of gabapentin in abdominal hysterectomy: a systematic review and meta-analysis","volume":"123","author":"Alayed","year":"2014","journal-title":"Obstet Gynecol"},{"key":"key2026020917224200_ref17-bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejogrb.2018.11.026","article-title":"Perioperative gabapentin and post cesarean pain control: a systematic review and meta-analysis of randomized controlled trials","volume":"233","author":"Felder","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key2026020917224200_ref18-bib18","doi-asserted-by":"crossref","first-page":"e3883","DOI":"10.1097\/MD.0000000000003883","article-title":"The use of gabapentin in the management of postoperative pain after total knee arthroplasty: a PRISMA-compliant meta-analysis of randomized controlled trials","volume":"95","author":"Han","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key2026020917224200_ref19-bib19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/lary.25636","article-title":"The efficacy of gabapentin\/pregabalin in improving pain after tonsillectomy: a meta-analysis","volume":"126","author":"Hwang","year":"2016","journal-title":"Laryngoscope"},{"key":"key2026020917224200_ref20-bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bjan.2016.07.005","article-title":"Perioperative gabapentin and pregabalin in cardiac surgery: a systematic review and meta-analysis","volume":"67","author":"Maitra","year":"2017","journal-title":"Braz J Anesthesiol"},{"key":"key2026020917224200_ref21-bib21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1177\/0194599816659042","article-title":"Gabapentin for perioperative analgesia in otorhinolaryngology\u2013head and neck surgery","volume":"155","author":"Sanders","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"key2026020917224200_ref22-bib22","article-title":"Single dose oral gabapentin for established acute postoperative pain in adults","volume":"2010","author":"Straube","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"key2026020917224200_ref23-bib23","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/anae.14796","article-title":"PROSPECT guideline for rotator cuff repair surgery: systematic review and procedure-specific postoperative pain management recommendations","volume":"74","author":"Toma","year":"2019","journal-title":"Anaesthesia"},{"key":"key2026020917224200_ref24-bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/ALN.0000000000003428","article-title":"Perioperative use of gabapentinoids for the management of postoperative acute pain: a systematic review and meta-analysis","volume":"133","author":"Verret","year":"2020","journal-title":"Anesthesiology"},{"key":"key2026020917224200_ref25-bib25","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1097\/BRS.0b013e3182a69b90","article-title":"Gabapentin and pregabalin in the management of postoperative pain after lumbar spinal surgery: a systematic review and meta-analysis","volume":"38","author":"Yu","year":"2013","journal-title":"Spine"},{"key":"key2026020917224200_ref26-bib26","doi-asserted-by":"crossref","first-page":"e3673","DOI":"10.1097\/MD.0000000000003673","article-title":"The effect of gabapentin on acute postoperative pain in patients undergoing total knee arthroplasty: a meta-analysis","volume":"95","author":"Zhai","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key2026020917224200_ref27-bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/bja\/aex117","article-title":"Predicting postoperative morbidity in adult elective surgical patients using the Surgical Outcome Risk Tool (SORT)","volume":"119","author":"Wong","year":"2017","journal-title":"Br J Anaesth"},{"key":"key2026020917224200_ref28-bib28","doi-asserted-by":"crossref","first-page":"e170123","DOI":"10.1001\/jamasurg.2017.0123","article-title":"Costs and consequences of early hospital discharge after major inpatient surgery in older adults","volume":"152","author":"Regenbogen","year":"2017","journal-title":"JAMA Surg"},{"key":"key2026020917224200_ref29-bib29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/bjs.9394","article-title":"Systematic review and meta-analysis of enhanced recovery programmes in surgical patients","volume":"101","author":"Nicholson","year":"2014","journal-title":"Br J Surg"},{"key":"key2026020917224200_ref30-bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MLR.0b013e3181c162a2","article-title":"Using instrument-defined health state transitions to estimate minimally important differences for four preference-based health-related quality of life instruments","volume":"48","author":"Luo","year":"2010","journal-title":"Med Care"},{"key":"key2026020917224200_ref31-bib31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.knee.2019.04.018","article-title":"Meaningful changes in the Short Form 12 physical and mental summary scores after total knee arthroplasty","volume":"26","author":"Clement","year":"2019","journal-title":"Knee"},{"key":"key2026020917224200_ref32-bib32","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acr.20449","article-title":"Estimation of minimum clinically important difference for pain in fibromyalgia","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key2026020917224200_ref33-bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cct.2003.10.016","article-title":"Assessment of blinding in clinical trials","volume":"25","author":"Bang","year":"2004","journal-title":"Control Clin Trials"},{"key":"key2026020917224200_ref34-bib34","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"key2026020917224200_ref35-bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol \u2013 a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"key2026020917224200_ref36-bib36","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"key2026020917224200_ref37-bib37","volume-title":"NICE Health Technology Evaluations: The Manual","author":"NICE","year":"2022"},{"key":"key2026020917224200_ref38-bib38","volume-title":"Costs Book 2019\u201320 \u2013 R140 Number of Theatres, Expenditure and Usage","author":"Public Health Scotland"},{"key":"key2026020917224200_ref39-bib39","volume-title":"Drugs and Pharmaceutical Electronic Market Information Tool (eMIT)","author":"Department of Health and Social Care"},{"key":"key2026020917224200_ref40-bib40","volume-title":"Prescription Cost Analysis \u2013 England \u2013 2021\/22","author":"NHS Business Services Authority"},{"key":"key2026020917224200_ref41-bib41","volume-title":"National Schedule of NHS Costs 2021\u201322","author":"NHS England"},{"key":"key2026020917224200_ref42-bib42","volume-title":"Unit Costs of Health and Social Care 2022 Manual","author":"Jones"},{"key":"key2026020917224200_ref43-bib43","volume-title":"National Schedule of Reference Costs 2017\u201318","author":"NHS Improvement"},{"key":"key2026020917224200_ref44-bib44","doi-asserted-by":"crossref","first-page":"e014815","DOI":"10.1136\/bmjopen-2016-014815","article-title":"Has the NHS 111 urgent care telephone service been a success? Case study and secondary data analysis in England","volume":"7","author":"Pope","year":"2017","journal-title":"BMJ Open."},{"key":"key2026020917224200_ref45-bib45","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"key2026020917224200_ref46-bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jhealeco.2017.06.013","article-title":"Econometric modelling of multiple self-reports of health states: the switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis","volume":"55","author":"Hern\u00e1ndez-Alava","year":"2017","journal-title":"J Health Econ"},{"key":"key2026020917224200_ref47-bib47","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s40273-014-0193-3","article-title":"A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials","volume":"32","author":"Faria","year":"2014","journal-title":"PharmacoEconomics"},{"key":"key2026020917224200_ref48-bib48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/hec.766","article-title":"Missing.... presumed at random: cost-analysis of incomplete data","volume":"12","author":"Briggs","year":"2003","journal-title":"Health Econ"},{"key":"key2026020917224200_ref49-bib49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"key2026020917224200_ref50-bib50","doi-asserted-by":"crossref","DOI":"10.1002\/9780470316696","volume-title":"Multiple Imputation for Non-response in Surveys","author":"Rubin","year":"1987"},{"key":"key2026020917224200_ref51-bib51","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hec.944","article-title":"Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility","volume":"14","author":"Manca","year":"2005","journal-title":"Health Econ"},{"key":"key2026020917224200_ref52-bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.jvca.2018.09.039","article-title":"Society of Cardiovascular Anesthesiologists\/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery","volume":"33","author":"O\u2019Brien","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"key2026020917224200_ref53-bib53","volume-title":"National Adult Cardiac Surgery Audit","author":"NHS England","year":"2023"},{"key":"key2026020917224200_ref54-bib54","first-page":"43","article-title":"Perioperative use of gabapentinoids in France. Mismatch between clinical practice and scientific evidence","volume":"37","author":"Martinez","year":"2018","journal-title":"Anaesth Crit Care Pain Med"},{"key":"key2026020917224200_ref55-bib55","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamainternmed.2017.7856","article-title":"Gabapentinoid use in the United States 2002 through 2015","volume":"178","author":"Johansen","year":"2018","journal-title":"JAMA Intern Med"},{"key":"key2026020917224200_ref56-bib56","doi-asserted-by":"crossref","first-page":"e2318626","DOI":"10.1001\/jamanetworkopen.2023.18626","article-title":"Trends in the use of gabapentinoids and opioids in the postoperative period among older adults","volume":"6","author":"Bongiovanni","year":"2023","journal-title":"JAMA Netw Open"},{"key":"key2026020917224200_ref57-bib57","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMp1806486","article-title":"The FDA and the next wave of drug abuse \u2013 proactive pharmacovigilance","volume":"379","author":"Throckmorton","year":"2018","journal-title":"N Engl J Med"},{"key":"key2026020917224200_ref58-bib58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of pregabalin and gabapentin","volume":"77","author":"Evoy","year":"2017","journal-title":"Drugs"},{"key":"key2026020917224200_ref59-bib59","volume-title":"Advice for Prescribers on the Risk of the Misuse of Pregabalin and Gabapentin","author":"NHS England","year":"2014"},{"key":"key2026020917224200_ref60-bib60","doi-asserted-by":"crossref","first-page":"f7615","DOI":"10.1136\/bmj.f7615","article-title":"Bad medicine: gabapentin and pregabalin","volume":"347","author":"Spence","year":"2013","journal-title":"BMJ"},{"key":"key2026020917224200_ref61-bib61","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse and diversion: a systematic review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"key":"key2026020917224200_ref62-bib62","doi-asserted-by":"crossref","first-page":"l2147","DOI":"10.1136\/bmj.l2147","article-title":"Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden","volume":"365","author":"Molero","year":"2019","journal-title":"BMJ"},{"key":"key2026020917224200_ref63-bib63","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpain.2015.12.008","article-title":"Management of Postoperative Pain: A Clinical Practice Guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists\u2019 Committee on Regional Anesthesia, Executive Committee, and Administrative Council","volume":"17","author":"Chou","year":"2016","journal-title":"J Pain"},{"key":"key2026020917224200_ref64-bib64","volume-title":"Better Postoperative Pain Management","author":"Prospect: Procedure-specific Postoperative Pain Management"},{"key":"key2026020917224200_ref65-bib65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/SPV.0000000000001064","article-title":"Randomized clinical trial of gabapentin versus placebo for pain after sacrospinous ligament fixation","volume":"28","author":"Wu","year":"2022","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"key2026020917224200_ref66-bib66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jmig.2020.04.040","article-title":"Preoperative gabapentin for minimally invasive hysterectomy: a randomized controlled trial","volume":"28","author":"Huynh","year":"2021","journal-title":"J Minim Invasive Gynecol"},{"key":"key2026020917224200_ref67-bib67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/AJP.0000000000001024","article-title":"Effects of gabapentin enacarbil on postoperative pain after hip and knee arthroplasty: a placebo-controlled randomized trial","volume":"38","author":"Ayad","year":"2022","journal-title":"Clin J Pain"},{"key":"key2026020917224200_ref68-bib68","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/bja\/aew466","article-title":"Measuring acute postoperative pain using the visual analog scale: the minimal clinically important difference and patient acceptable symptom state","volume":"118","author":"Myles","year":"2017","journal-title":"Br J Anaesth"},{"key":"key2026020917224200_ref69-bib69","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/aas.12651","article-title":"Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice","volume":"60","author":"Feldheiser","year":"2016","journal-title":"Acta Anaesthesiol Scand"},{"key":"key2026020917224200_ref70-bib70","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ejcts\/ezy301","article-title":"Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS\u00ae) Society and the European Society of Thoracic Surgeons (ESTS)","volume":"55","author":"Batchelor","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"key2026020917224200_ref71-bib71","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamasurg.2019.1153","article-title":"Guidelines for perioperative care in cardiac surgery: enhanced recovery after surgery society recommendations","volume":"154","author":"Engelman","year":"2019","journal-title":"JAMA Surg"},{"key":"key2026020917224200_ref72-bib72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pain.2006.06.018","article-title":"Gabapentin and postoperative pain \u2013 a systematic review of randomized controlled trials","volume":"126","author":"Ho","year":"2006","journal-title":"Pain"},{"key":"key2026020917224200_ref73-bib73","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/anae.13179","article-title":"A systematic review and meta-regression analysis of prophylactic gabapentin for postoperative pain","volume":"70","author":"Doleman","year":"2015","journal-title":"Anaesthesia"},{"key":"key2026020917224200_ref74-bib74","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/AJP.0000000000000285","article-title":"Time to onset of sustained postoperative pain relief (SuPPR): evaluation of a new systems-level metric for acute pain management","volume":"32","author":"Tighe","year":"2016","journal-title":"Clin J Pain"},{"key":"key2026020917224200_ref75-bib75","volume-title":"NHS Tarrif 2020\/21","author":"NHS England"},{"key":"key2026020917224200_ref76-bib76","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bja.2020.05.017","article-title":"Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland","volume":"125","author":"Torrance","year":"2020","journal-title":"Br J Anaesth"},{"key":"key2026020917224200_ref77-bib77","doi-asserted-by":"crossref","first-page":"664","DOI":"10.15585\/mmwr.mm7119a3","article-title":"Notes from the field: trends in gabapentin detection and involvement in drug overdose deaths \u2013 23 states and the district of Columbia, 2019\u20132020","volume":"71","author":"Mattson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key2026020917224200_ref78-bib78","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k4364","volume-title":"Pregabalin and Gabapentin Become Controlled Drugs to Cut Deaths from Misuse","author":"Mayor","year":"2018"},{"key":"key2026020917224200_ref79-bib79","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1111\/jgs.18005","article-title":"Prolonged use of newly prescribed gabapentin after surgery","volume":"70","author":"Bongiovanni","year":"2022","journal-title":"J Am Geriatr Soc"},{"key":"key2026020917224200_ref80-bib80","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.arth.2022.05.018","article-title":"Perioperative use of gabapentinoids and risk for postoperative long-term opioid use in older adults undergoing total knee or hip arthroplasty","volume":"37","author":"Chen","year":"2022","journal-title":"J Arthroplasty"},{"key":"key2026020917224200_ref81-bib81","volume-title":"Peri-operative Quality Improvement Programme Report","author":"Royal College of Anaesthetists","year":"2023"},{"key":"key2026020917224200_ref82-bib82","volume-title":"NICE Medical Technology Guidance 8: The VeriQ System for Assessing Graft Flow During Coronary Artery Bypass Graft Surgery","author":"National Institute for Health and Care Excellence"},{"key":"key2026020917224200_ref83-bib83","volume-title":"Nutrition Support in Adults: Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition. Costing Report. Implementing NICE Guidance in England. NICE Clinical Guideline no. 32","author":"National Institute for Health and Clinical Excellence"},{"key":"key2026020917224200_ref84-bib84","volume-title":"NHS Blood and Transplant Price List 2021\u201322","author":"NHS Blood and Transplant"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2049962","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/sites\/journalslibrary\/files\/journal_data\/PLMH9787\/PLMH9787.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2049962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T11:56:45Z","timestamp":1770638205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/PLMH9787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":82,"alternative-id":["10.3310\/PLMH9787"],"URL":"https:\/\/doi.org\/10.3310\/plmh9787","relation":{},"ISSN":["2046-4924"],"issn-type":[{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"06-2017","name":"contractual_start_date","label":"contractual_start_date","group":{"name":"article_history","label":"Article History"}},{"value":"10-2023","name":"editorial_review_begun","label":"editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"01-2025","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}